Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,704.60
+9.50 (0.56%)
At close: Feb 9, 2026

NSE:SUNPHARMA Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
4,067,1134,162,1263,888,2422,358,7292,194,7371,434,322
Market Cap Growth
-3.84%7.04%64.84%7.47%53.02%69.69%
Enterprise Value
3,843,5283,989,2713,792,9042,296,4952,136,3761,424,670
Last Close Price
1695.101717.851590.15955.81879.84568.99
PE Ratio
37.2938.0840.6027.8467.0649.39
Forward PE
33.3035.8042.3628.9728.5426.49
PS Ratio
7.167.928.025.385.684.28
PB Ratio
5.215.745.793.984.302.90
P/TBV Ratio
7.417.678.396.166.234.16
P/FCF Ratio
-34.8539.1482.0829.3028.69
P/OCF Ratio
-29.5832.0447.5624.4323.25
PEG Ratio
2.832.392.971.991.461.31
EV/Sales Ratio
6.777.597.825.235.534.25
EV/EBITDA Ratio
23.8426.6529.4619.7121.0417.07
EV/EBIT Ratio
28.2431.6536.0524.6826.1922.17
EV/FCF Ratio
-33.4038.1879.9128.5328.49
Debt / Equity Ratio
0.070.030.050.120.030.08
Debt / EBITDA Ratio
0.320.160.250.580.130.46
Debt / FCF Ratio
-0.200.332.400.170.77
Asset Turnover
-0.590.580.580.560.49
Inventory Turnover
-1.101.081.121.171.05
Quick Ratio
-2.171.821.361.371.20
Current Ratio
-2.892.562.002.031.89
Return on Equity (ROE)
-15.71%15.20%15.43%6.74%4.61%
Return on Assets (ROA)
-8.87%7.91%7.73%7.42%5.91%
Return on Invested Capital (ROIC)
18.26%20.12%17.87%18.65%14.83%11.61%
Return on Capital Employed (ROCE)
-17.10%15.40%15.30%15.50%12.50%
Earnings Yield
2.68%2.63%2.46%3.59%1.49%2.02%
FCF Yield
-2.87%2.56%1.22%3.41%3.49%
Dividend Yield
0.94%0.93%0.85%1.20%1.14%1.32%
Payout Ratio
36.30%33.07%30.26%29.73%65.97%53.70%
Buyback Yield / Dilution
-0.24%-----
Total Shareholder Return
0.71%0.93%0.85%1.20%1.14%1.32%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.